Merck KGaA (MRK)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

€118.00

Buy

€118.55

arrow-up€0.00 (+0.00%)

Prices updated at 12 Dec 2025, 20:47 CET

Prices minimum 15 mins delay

Prices in EUR

Merck KGaA is a pharmaceutical and chemical company. It offers prescription medicines, diagnostics, and products used in allergen immunotherapy, specialty chemicals, and probiotic nutritional supplements.

FTSE EuroFirst 300

-0.53%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Chairman

Mr. Sascha Held

CEO

-

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

63,160

Head office

Frankfurter Strasse 250

Darmstadt

Germany

64293

+49 6151720

-

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Michael Kleinemeier Chairman of the Supervisory Board	-
Ms. Carla Kriwet Member of the Supervisory Board	-
Dr. Susanne Schaffert, PhD Member of the Supervisory Board	-
Ms. Barbara Lambert Member of the Supervisory Board	-
Ms. Birgit Biermann Member of the Supervisory Board	-
Mr. Sascha Held Vice Chairman of the Supervisory Board	-
Ms. Anne Lange Member of the Supervisory Board	-
Mr. Dietmar Oeter Member of the Supervisory Board	-
Mr. Alexander Putz Member of the Supervisory Board	-
Mr. Christian Raabe Member of the Supervisory Board	-
Mr. Daniel Thelen Member of the Supervisory Board	-
Mr. Simon Thelen Member of the Supervisory Board	-
Ms. Katja Garcia Vila Member of the Supervisory Board	-
Mr. Stefan Palzer Member of the Supervisory Board	-
Mr. Michael Reinhart Member of the Supervisory Board	-
Ms. Sandra Schwebke Member of the Supervisory Board	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
First Eagle Investment Management, LLC	9,071,066
First Eagle Global Fund	6,071,389
MFS Investment Management	6,051,642
Massachusetts Financial Services Company	5,972,637
Vanguard Group Inc	3,930,333

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.